PPL Corp (PPL) 34.40 $PPL PPL Stock Rating Upgraded at

New Post Public Reply Private Reply Replies (0) Message Board

Nov 1, 2015 at 5:42 PM

PPL Corp (PPL) 34.40 $PPL

PPL Stock Rating Upgraded at Deutsche Bank
at The Street - Fri Oct 30, 8:48AM CDT
PPL stock was upgraded to 'buy' from 'hold' at Deutsche Bank on Friday.
PPL: 34.40 (+0.61)

Electric Utilities Seek to Shock Shares Through Mergers
at The Street - Fri Oct 30, 8:37AM CDT
Industry deal volume and value are up sharply this year as utilities look to spur growth.
TE: 27.00 (-0.11), CPN: 15.51 (+0.57), PNY: 57.31 (+0.06), DUK: 71.47 (-0.10), EXC: 27.92 (-0.67), TLN: 8.68 (+0.01), SO: 45.10 (+0.15), AEP: 56.65 (+0.44), ETR: 68.16 (+0.66), FSLR: 57.07 (+6.08), POM: 26.63 (+0.03), AES: 10.95 (-0.05), TRP: 33.59 (-0.28), PPL: 34.40 (+0.61), NRG: 12.89 (unch)

Analysts' Actions -- Vertex, LinkedIn, BE/Aerospace, DreamWorks, Starbucks
at The Street - Fri Oct 30, 8:33AM CDT
Here are Friday's top research calls, including new ratings at LinkedIn, BE/Aerospace, DreamWorks, Starbucks, Vertex and more.
WFM: 29.96 (-0.19), VRTX: 124.74 (-1.43), OLN: 19.18 (+0.56), DWA: 20.24 (-1.70), SBUX: 62.57 (+0.07), BWA: 42.82 (+1.25), EVER: 17.26 (-0.78), ON: 11.00 (+0.72), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), PPL: 34.40 (+0.61), PZZA: 70.17 (-3.14), EXPE: 136.30 (+9.24), FBC: 22.24 (-0.84), BEAV: 46.95 (-0.61), PPC: 18.99 (+0.42), GPS: 27.22 (+0.52), IMPV: 70.62 (+9.81)

Upgrade Alert for PPL (PPL)
Comtex SmarTrend(R) - Fri Oct 30, 7:24AM CDT
PPL (NYSE

PL) was upgraded from Hold to Buy at Deutsche Bank today. The stock closed yesterday at $33.78 on volume of 6.6 million shares, above average daily volume of 5.1 million. PPL Corporation is an energy and utility holding company. The Company, through its subsidiaries, generates electricity from power plants in the northeastern and western United States, and markets wholesale and retail energy primarily in the northeastern and western portions of the United States, and delivers electricity in Pennsylvania and the United Kingdom.
PPL: 34.40 (+0.61)

PPL Corp. Beats Q3 Earnings Estimates, Misses on Revenues
Zacks Equity Research - Zacks Investment Research - Thu Oct 29, 12:55PM CDT
PPL Corporation reported third-quarter 2015 adjusted earnings of 51 cents per share, surpassing the Zacks Consensus Estimate of 48 cents by 6.25%.
ES: 50.94 (+0.18), EXC: 27.92 (-0.67), PPL: 34.40 (+0.61), LNT: 59.02 (+0.35)

Stock Market News for October 29, 2015
Zacks Equity Research - Zacks Investment Research - Thu Oct 29, 9:10AM CDT
Benchmarks rebounded strongly on Wednesday to end in the green after the Fed signaled a rate hike possibility in December
71.43 (+0.55), PCG: 53.40 (+1.05), DUK: 71.47 (-0.10), AKAM: 60.82 (-0.29), C: 53.17 (-0.49), XOM: 82.74 (+0.51), BAC: 16.78 (-0.31), MS: 32.97 (-0.57), NEE: 102.66 (+0.88), PXD: 137.14 (-0.89), JPM: 64.25 (-0.96), PPL: 34.40 (+0.61), EOG: 85.85 (+0.33), CVX: 90.88 (+0.99), OXY: 74.54 (+0.41), BK: 41.65 (-0.80), AAPL: 119.50 (-1.03)

PPL Corporation Tops Q3 Earnings, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Thu Oct 29, 7:42AM CDT
PPL Corp. surpassed the third quarter earnings estimates. Our consensus called for third-quarter EPS of 48 cents, and the company reported EPS of 51 cents.
PPL: 34.40 (+0.61)

PPL beats 3Q profit forecasts
Automated Insights - Thu Oct 29, 6:17AM CDT
ALLENTOWN, Pa. (AP) _ PPL Corp. (PPL) on Thursday reported third-quarter net income of $393 million.
PPL: 34.40 (+0.61)

PPL Corporation Reports Third-Quarter Earnings
PR Newswire - Thu Oct 29, 5:55AM CDT
PPL Corporation on Thursday (10/29) announced third-quarter 2015 reported earnings of $393 million, or $0.58 per share, a decrease from $497 million, or $0.74 per share, a year ago.
PPL: 34.40 (+0.61)

Look for Shares of PPL to Potentially Rebound after Yesterday's 2.57% Sell Off
Comtex SmarTrend(R) - Wed Oct 28, 5:16PM CDT
PPL (NYSE

PL) traded in a range yesterday that spanned from a low of $33.13 to a high of $34.47. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $33.90 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PPL: 34.40 (+0.61)

PPL Electric Utilities Seeks Approval for First Segment Of Proposed New Transmission Line
PR Newswire - Wed Oct 28, 3:30PM CDT
PPL Electric Utilities Corporation, a subsidiary of PPL Corporation (NYSE: PPL), has begun the application and approval process for the first segment of Project Compass - a major new transmission line proposed by PPL Electric Utilities to provide significant benefits for consumers.
PPL: 34.40 (+0.61)

PPL Electric Utilities assessing apparent damage from runaway blimp
PR Newswire - Wed Oct 28, 3:21PM CDT
PPL Electric Utilities is assessing and responding to damage to its electric delivery system reportedly caused Wednesday afternoon (10/28) by a runaway military blimp.
PPL: 34.40 (+0.61)

What's in Store for PPL Corp. (PPL) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 3:30PM CDT
PPL Corporation will release third-quarter 2015 financial results before the market opens on Oct 29, 2015.
DUK: 71.47 (-0.10), PPL: 34.40 (+0.61), WEC: 51.56 (+0.26), LNT: 59.02 (+0.35)

PPL Corp Inks Coal Supply Agreement with Paringa Resources
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 3:50PM CDT
Louisville Gas and Electric Company and Kentucky Utilities Company , subsidiaries of PPL Corporation , have executed an agreement with Paringa Resources Limited for the future purchase of coal from the proposed Buck Creek No.1 mine.
AEP: 56.65 (+0.44), XEL: 35.63 (+0.09), CNX: 6.66 (-0.11), PPL: 34.40 (+0.61)

Shares of PPL Up 7.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 19, 10:17AM CDT
SmarTrend identified an Uptrend for PPL (NYSE

PL) on September 25th, 2015 at $31.80. In approximately 3 weeks, PPL has returned 7.55% as of today's recent price of $34.20.
PPL: 34.40 (+0.61)

PPL Corporation to Conduct Webcast on 2015 Third-Quarter Earnings Results
PR Newswire - Mon Oct 19, 9:24AM CDT
PPL Corporation (NYSE: PPL) will release consolidated third-quarter 2015 earnings results before the stock market opens on Thursday, Oct. 29.
PPL: 34.40 (+0.61)

Downgrade Alert for PPL (PPL)
Comtex SmarTrend(R) - Mon Oct 19, 7:11AM CDT
PPL (NYSE

PL) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $34.46 on volume of 4.4 million shares, below average daily volume of 5.3 million. PPL (NYSE

PL) is currently priced 0.3% above its average consensus analyst price target of $34.34. PPL shares have support at the 200-day moving average (MA) of $32.87 and additional support at the 50-day MA of $31.92.
PPL: 34.40 (+0.61)

Paringa Contracts Future Coal Sales Totaling US$220 Million With A Major Utility
PR Newswire - Sun Oct 18, 7:15PM CDT
HIGHLIGHTS:
PPL: 34.40 (+0.61)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...